HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 11, November 2018 – The Asian Cancer - War on liver cancer       » 2018 Nobel Prize in Physiology or Medicine winners       » Women more prone to selected chemotherapy side effects       » Tibetan fungus could help fight liver cancer       » Standards for TCM decoction to be applied globally       » RMB200 million donation to build Tsinghua University Biomedical Sciences Building      
INSIDE INDUSTRY
Merck invests SGD20 million laboratory in Singapore
First GMP BioReliance biosafety testing lab in Asia Pacific offering critical testing services to bring life-changing therapies to market

Merck has opened a new SGD20 million laboratory in Singapore. The 3,800-square-meter lab is the first of its kind outside of the US and UK, and the first in Singapore.

Biologics testing is a major step in the drug development process to ensure sterility, safety and overall quality of customers’ biological drug products.

The lab will support biotech and pharma customers in Singapore and the Asia Pacific region and accelerate speed-to-market for drug therapies.

The new one-stop Singapore lab consists of three different labs:

  • M Lab Collaboration Center is designed to recreate an actual manufacturing environment, and offers non-GMP lab space for training, hands-on demonstrations and process optimisation through various stages of biopharmaceutical development and manufacturing. The flexible lab allows customers to recreate their specific processes for troubleshooting critical process issues without impacting their own production line.

  • BioReliance Biosafety Testing Service Lab is the only lab in Asia-Pacific offering lot release testing (tests product biosafety profile during bioprocessing), viral clearance testing (validate client's process capability to remove adventitious viruses) and biorepository (stores precious cell banks and provide a global network of storage facilities to mitigate risk and convenient access to customer’s cell banks). These crucial safety-testing services ensure the safe release of leading medicines to patients around the world.

  • Media Development Services Lab which offers services including customised cell culture media and feed development services for biopharma customers.

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management - Technologies for biotech and pharmaceutical industries
August:
Regenerative technology - Meat of the future
September:
Doctor Robot - The digital healthcare revolution
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy